TY - JOUR AU - Assmann, G. AU - Schulte, H. PY - 1992 DA - 1992// TI - Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience) JO - Prospective Cardiovascular Munster study Am J Cardiol VL - 70 ID - Assmann1992 ER - TY - JOUR AU - Davis, N. E. PY - 2005 DA - 2005// TI - Atherosclerosis--an inflammatory process JO - J Insur Med VL - 37 ID - Davis2005 ER - TY - JOUR AU - Dobiásová, M. AU - Frohlich, J. PY - 2001 DA - 2001// TI - The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)) JO - Clin Biochem VL - 34 UR - https://doi.org/10.1016/S0009-9120(01)00263-6 DO - 10.1016/S0009-9120(01)00263-6 ID - Dobiásová2001 ER - TY - JOUR AU - Zhu, X. W. AU - Deng, F. Y. AU - Lei, S. F. PY - 2015 DA - 2015// TI - Meta-analysis of Atherogenic index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus JO - Prim Care Diabetes VL - 9 UR - https://doi.org/10.1016/j.pcd.2014.03.007 DO - 10.1016/j.pcd.2014.03.007 ID - Zhu2015 ER - TY - JOUR AU - Beisiegel, U. PY - 1998 DA - 1998// TI - Lipoprotein metabolism JO - Eur Heart J VL - 19 ID - Beisiegel1998 ER - TY - JOUR AU - Frank, P. G. AU - Marcel, Y. L. PY - 2000 DA - 2000// TI - Apolipoprotein A-I: structure-function relationships JO - J Lipid Res VL - 41 ID - Frank2000 ER - TY - JOUR AU - Packard, C. J. AU - Shepherd, J. PY - 1997 DA - 1997// TI - Lipoprotein heterogeneity and apolipoprotein B metabolism JO - Arterioscler Thromb Vasc Biol VL - 17 UR - https://doi.org/10.1161/01.ATV.17.12.3542 DO - 10.1161/01.ATV.17.12.3542 ID - Packard1997 ER - TY - JOUR AU - Rifai, N. AU - Chapman, J. F. AU - Silverman, L. M. AU - Gwynnes, J. T. PY - 1988 DA - 1988// TI - Review of serum lipids and apolipoproteins in risk-assessment of coronary heart disease JO - Ann Clin Lab Sci VL - 18 ID - Rifai1988 ER - TY - JOUR AU - Zambon, A. AU - Brown, B. G. AU - Deeb, S. S. AU - Brunzell, J. D. PY - 2006 DA - 2006// TI - Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease JO - J Intern Med VL - 259 UR - https://doi.org/10.1111/j.1365-2796.2006.01645.x DO - 10.1111/j.1365-2796.2006.01645.x ID - Zambon2006 ER - TY - JOUR AU - Walldius, G. AU - Jungner, I. AU - Holme, I. AU - Aastveit, A. H. AU - Kolar, W. AU - Steiner, E. PY - 2001 DA - 2001// TI - High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)07098-2 DO - 10.1016/S0140-6736(01)07098-2 ID - Walldius2001 ER - TY - JOUR AU - Yusuf, S. AU - Hawken, S. AU - Ounpuu, S. AU - Dans, T. AU - Avezum, A. AU - Lanas, F. PY - 2004 DA - 2004// TI - Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17018-9 DO - 10.1016/S0140-6736(04)17018-9 ID - Yusuf2004 ER - TY - JOUR AU - Vaessen, S. F. AU - Schaap, F. G. AU - Kuivenhoven, J. A. AU - Groen, A. K. AU - Hutten, B. A. AU - Boekholdt, S. M. PY - 2006 DA - 2006// TI - Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk population study JO - J Lipid Res VL - 47 UR - https://doi.org/10.1194/jlr.M600233-JLR200 DO - 10.1194/jlr.M600233-JLR200 ID - Vaessen2006 ER - TY - JOUR AU - Dunder, K. AU - Lind, L. AU - Zethelius, B. AU - Berglund, L. AU - Lithell, H. PY - 2004 DA - 2004// TI - Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala longitudinal study of adult men (ULSAM) JO - Am Heart J VL - 148 UR - https://doi.org/10.1016/j.ahj.2004.03.021 DO - 10.1016/j.ahj.2004.03.021 ID - Dunder2004 ER - TY - JOUR AU - Meisinger, C. AU - Loewel, H. AU - Mraz, W. AU - Koenig, W. PY - 2005 DA - 2005// TI - Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study JO - Eur Heart J VL - 26 UR - https://doi.org/10.1093/eurheartj/ehi003 DO - 10.1093/eurheartj/ehi003 ID - Meisinger2005 ER - TY - JOUR AU - Sierra-Johnson, J. AU - Romero-Corral, A. AU - Somers, V. K. AU - Lopez-Jimenez, F. AU - Walldius, G. AU - Hamsten, A. PY - 2007 DA - 2007// TI - ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects JO - Eur Heart J VL - 28 UR - https://doi.org/10.1093/eurheartj/ehm360 DO - 10.1093/eurheartj/ehm360 ID - Sierra-Johnson2007 ER - TY - JOUR AU - Thompson, A. AU - Danesh, J. PY - 2006 DA - 2006// TI - Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies JO - J Intern Med VL - 259 UR - https://doi.org/10.1111/j.1365-2796.2006.01644.x DO - 10.1111/j.1365-2796.2006.01644.x ID - Thompson2006 ER - TY - JOUR AU - Sniderman, A. D. AU - Jungner, I. AU - Holme, I. AU - Aastveit, A. AU - Walldius, G. PY - 2006 DA - 2006// TI - Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease JO - J Intern Med VL - 259 UR - https://doi.org/10.1111/j.1365-2796.2006.01649.x DO - 10.1111/j.1365-2796.2006.01649.x ID - Sniderman2006 ER - TY - JOUR AU - Ginsburg, G. S. AU - Safran, C. AU - Pasternak, R. C. PY - 1991 DA - 1991// TI - Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels JO - Am J Cardiol VL - 68 UR - https://doi.org/10.1016/0002-9149(91)90742-4 DO - 10.1016/0002-9149(91)90742-4 ID - Ginsburg1991 ER - TY - JOUR AU - Lennep, J. E. AU - Westerveld, H. T. AU - Lennep, H. W. AU - Zwinderman, A. H. AU - Erkelens, D. W. AU - Wall, E. E. PY - 2000 DA - 2000// TI - Apolipoprotein concentrations during treatment and recurrent coronary artery disease events JO - Arterioscler Thromb Vasc Biol VL - 20 UR - https://doi.org/10.1161/01.ATV.20.11.2408 DO - 10.1161/01.ATV.20.11.2408 ID - Lennep2000 ER - TY - JOUR AU - Sniderman, A. D. AU - Pedersen, T. AU - Kjekshus, J. PY - 1997 DA - 1997// TI - Putting low-density lipoproteins at center stage in atherogenesis JO - Am J Cardiol VL - 79 UR - https://doi.org/10.1016/S0002-9149(96)00677-7 DO - 10.1016/S0002-9149(96)00677-7 ID - Sniderman1997 ER - TY - JOUR AU - Carnevale Schianca, G. P. AU - Pedrazzoli, R. AU - Onolfo, S. AU - Colli, E. AU - Cornetti, E. AU - Bergamasco, L. PY - 2011 DA - 2011// TI - ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk JO - Nutr Metab Cardiovasc Dis VL - 21 UR - https://doi.org/10.1016/j.numecd.2009.11.002 DO - 10.1016/j.numecd.2009.11.002 ID - Carnevale Schianca2011 ER - TY - JOUR AU - Mathur, R. AU - Sharma, A. AU - Dixit, V. P. AU - Varma, M. PY - 1996 DA - 1996// TI - Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits JO - J Ethnopharmacol VL - 50 UR - https://doi.org/10.1016/0378-8741(95)01308-3 DO - 10.1016/0378-8741(95)01308-3 ID - Mathur1996 ER - TY - JOUR AU - Jacob, A. AU - Pandey, M. AU - Kapoor, S. AU - Saroja, R. PY - 1988 DA - 1988// TI - Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years JO - Eur J Clin Nutr VL - 42 ID - Jacob1988 ER - TY - JOUR AU - Anila, L. AU - Vijayalakshmi, N. R. PY - 2002 DA - 2002// TI - Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia JO - J Ethnopharmacol VL - 79 UR - https://doi.org/10.1016/S0378-8741(01)00361-0 DO - 10.1016/S0378-8741(01)00361-0 ID - Anila2002 ER - TY - JOUR AU - Antony, B. AU - Merina, B. AU - Sheeba, V. AU - Mukkadan, J. PY - 2006 DA - 2006// TI - Effect of standardized Amla extract on atherosclerosis and dyslipidemia JO - Indian J Pharm Sci VL - 68 UR - https://doi.org/10.4103/0250-474X.27814 DO - 10.4103/0250-474X.27814 ID - Antony2006 ER - TY - JOUR AU - Mishra, M. AU - Pathak, U. N. AU - Khan, A. B. PY - 1981 DA - 1981// TI - Emblica officinalis Gaertn and serum cholesterol level in experimental rabbits JO - Br J Exp Pathol VL - 62 ID - Mishra1981 ER - TY - JOUR AU - Thakur, C. P. AU - Mandal, K. PY - 1984 DA - 1984// TI - Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits JO - Ind J Med Res VL - 79 ID - Thakur1984 ER - TY - JOUR AU - Antony, B. AU - Benny, M. AU - Kaimal, T. N. PY - 2008 DA - 2008// TI - A pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax) on markers of systemic inflammation and dyslipidemia JO - Indian J Clin Biochem VL - 23 UR - https://doi.org/10.1007/s12291-008-0083-6 DO - 10.1007/s12291-008-0083-6 ID - Antony2008 ER - TY - JOUR AU - Antony, B. AU - Merina, B. AU - Sheeba, V. PY - 2008 DA - 2008// TI - Amlamax in the management of dyslipidemia in humans JO - Indian J Pharm Sci VL - 70 UR - https://doi.org/10.4103/0250-474X.44604 DO - 10.4103/0250-474X.44604 ID - Antony2008 ER - TY - JOUR AU - Gopa, B. AU - Bhatt, J. AU - Hemavathi, K. G. PY - 2012 DA - 2012// TI - A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-a reductase inhibitor simvastatin JO - Indian J Pharmacol VL - 44 UR - https://doi.org/10.4103/0253-7613.93857 DO - 10.4103/0253-7613.93857 ID - Gopa2012 ER - TY - JOUR AU - Muthayya, S. AU - Sugimoto, J. D. AU - Montgomery, S. AU - Maberly, G. F. PY - 2014 DA - 2014// TI - An overview of global rice production, supply, trade, and consumption JO - Ann N Y Acad Sci VL - 1324 UR - https://doi.org/10.1111/nyas.12540 DO - 10.1111/nyas.12540 ID - Muthayya2014 ER - TY - JOUR AU - Ray, M. AU - Ghosh, K. AU - Singh, S. AU - Mondal, K. C. PY - 2016 DA - 2016// TI - Folk to functional: an explorative overview of rice-based fermented foods and beverages in India JO - J Ethnic Foods VL - 3 UR - https://doi.org/10.1016/j.jef.2016.02.002 DO - 10.1016/j.jef.2016.02.002 ID - Ray2016 ER - TY - JOUR AU - Cicero, A. F. G. AU - Derosa, G. PY - 2005 DA - 2005// TI - Rice bran and its main components: potential role in the management of coronary risk factors JO - Curr Top Nutraceutical Res VL - 3 ID - Cicero2005 ER - TY - STD TI - Borresen EC, Jenkins-Puccetti N, Schmitz K, Brown DG, Pollack A, Fairbanks A. A pilot randomized controlled clinical trial to assess tolerance and efficacy of navy bean and Rice bran supplementation for lowering cholesterol in children. Glob Pediatr Health. 2017;16, 4. https://doi.org/10.1177/2333794X17694231 PubMed PMID: 28345013. ID - ref34 ER - TY - JOUR AU - Dobiasova, M. PY - 2004 DA - 2004// TI - Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications JO - Clin Chem VL - 50 UR - https://doi.org/10.1373/clinchem.2004.033175 DO - 10.1373/clinchem.2004.033175 ID - Dobiasova2004 ER - TY - JOUR AU - Havel, R. J. PY - 2000 DA - 2000// TI - Remnant lipoproteins as therapeutic targets JO - Curr Opin Lipidol VL - 11 UR - https://doi.org/10.1097/00041433-200012000-00008 DO - 10.1097/00041433-200012000-00008 ID - Havel2000 ER - TY - JOUR AU - Fontbonne, A. AU - Eschwège, E. PY - 1991 DA - 1991// TI - Insulin-resistance, hypertriglyceridaemia and cardiovascular risk: the Paris prospective study JO - Diabete Metab VL - 17 ID - Fontbonne1991 ER - TY - JOUR AU - Joseph, J. P. AU - Afonso, M. AU - Berdai, D. AU - Salles, N. AU - Benard, A. AU - Gay, B. PY - 2015 DA - 2015// TI - Benefits and risks for primary prevention with statins in the elderly JO - Presse Med VL - 44 UR - https://doi.org/10.1016/j.lpm.2015.09.015 DO - 10.1016/j.lpm.2015.09.015 ID - Joseph2015 ER - TY - JOUR AU - Ridker, P. M. AU - Danielson, E. AU - Fonseca, F. A. AU - Genest, J. AU - Gotto, A. M. AU - Kastelein, J. J. PY - 2008 DA - 2008// TI - Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0807646 DO - 10.1056/NEJMoa0807646 ID - Ridker2008 ER - TY - JOUR AU - Sattar, N. AU - Preiss, D. AU - Murray, H. M. AU - Welsh, P. AU - Buckley, B. M. AU - Craen, A. J. PY - 2010 DA - 2010// TI - Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61965-6 DO - 10.1016/S0140-6736(09)61965-6 ID - Sattar2010 ER - TY - JOUR AU - Wang, K. L. AU - Liu, C. J. AU - Chao, T. F. AU - Huang, C. M. AU - Wu, C. H. AU - Chen, S. J. PY - 2012 DA - 2012// TI - Statins, risk of diabetes, and implications on outcomes in the general population JO - J Am Coll Cardiol VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.05.019 DO - 10.1016/j.jacc.2012.05.019 ID - Wang2012 ER - TY - JOUR AU - Waters, D. D. AU - Ho, J. E. AU - DeMicco, D. A. AU - Breazna, A. AU - Arsenault, B. J. AU - Wun, C. C. PY - 2011 DA - 2011// TI - Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials JO - J Am Coll Cardiol VL - 57 UR - https://doi.org/10.1016/j.jacc.2010.10.047 DO - 10.1016/j.jacc.2010.10.047 ID - Waters2011 ER - TY - STD TI - US Food and Drug Administration. FDA drug safety communication: important safety label changes to cholesterol lowering statin drugs. www.fda.gov/Drugs/DrugSafety/ucm293101.htm UR - http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm ID - ref43 ER -